SUBSCRIBE
SUBSCRIBE
News   Drug Development

Pfizer Inc. (JOBS) Halts Heart Disease, Obesity Research; Focuses on Cancer

September 30, 2008 | 
1 min read
Sept. 30 (Bloomberg) -- Pfizer Inc., the world's largest drugmaker, is ending early-stage development of treatments for a range of illnesses from obesity to heart disease, to focus on more profitable diseases.
Clinical research Phase I
MORE ON THIS TOPIC
Contemporary art collage of a hand holding scissors. Copy space for ad. Modern design.
Regulatory
Krystal Cuts Melanoma Study of Viral Immunotherapy as FDA ‘Uncertainty’ Muddies Approval Pathway
August 22, 2025
 · 
2 min read
 · 
Tristan Manalac
Glowing red neon heartbeat pulse rate line. Health and Medical concept. EKG Pulse Wave, cardiogram and rhythm
Duchenne muscular dystrophy
With Prasad Back at FDA, Capricor To Fight DMD Cardiomyopathy Rejection
August 20, 2025
 · 
7 min read
 · 
Heather McKenzie
Abstract creative art collage, market declines in the stock market. The concept of collapse or bankruptcy.
Weight loss
Viking Crashes as Obesity Pill Delivers Over 12% Weight Loss
August 19, 2025
 · 
2 min read
 · 
Tristan Manalac
Hands in black and white dropping a collection of pills on a pink background
Manufacturing
Oral Wegovy’s Pending Approval Puts Spotlight on Viability of High-Dose Peptides
August 19, 2025
 · 
5 min read
 · 
Nick Paul Taylor